BestFIT Sequential Multiple Assignment Randomized Trial Results: A SMART Approach to Developing Individualized Weight Loss Treatment Sequences.
BestFIT Sequential Multiple Assignment Randomized Trial Results: A SMART Approach to Developing Individualized Weight Loss Treatment Sequences.
复制标题
BestFIT 序贯多重分配随机试验结果:开发个体化减肥治疗序列的明智方法。
DOI:
10.1093/abm/kaab061
复制
发表时间:
2022
期刊:
影响因子:
--
通讯作者:
Jeffery,RobertW
中科院分区:
文献类型:
--
作者:
Sherwood,NancyE;Crain,ALauren;Seburg,ElisabethM;Butryn,MeghanL;Forman,EvanM;Crane,MelissaM;Levy,RonaL;Kunin-Batson,AliciaS;Jeffery,RobertW
BackgroundState-of-the-art behavioral weight loss treatment (SBT) can lead to clinically meaningful weight loss, but only 30–60% achieve this goal. Developing adaptive interventions that change based on individual progress could increase the number of people who benefit.PurposeConduct a Sequential Multiple Assignment Randomized Trial (SMART) to determine the optimal time to identify SBT suboptimal responders and whether it is better to switch to portion-controlled meals (PCM) or acceptance-based treatment (ABT).MethodThe BestFIT trial enrolled 468 adults with obesity who started SBT and were randomized to treatment response assessment at Session 3 (Early TRA) or 7 (Late TRA). Suboptimal responders were re-randomized to PCM or ABT. Responders continued SBT. Primary outcomes were weight change at 6 and 18 months.ResultsPCM participants lost more weight at 6 months (−18.4 lbs, 95% CI −20.5, −16.2) than ABT participants (−15.7 lbs, 95% CI: −18.0, −13.4), but this difference was not statistically significant (−2.7 lbs, 95% CI: −5.8, 0.5,p= .09). PCM and ABT participant 18 month weight loss did not differ. Early and Late TRA participants had similar weight losses (p= .96), however, Early TRA PCM participants lost more weight than Late TRA PCM participants (p= .03).ConclusionsResults suggest adaptive intervention sequences that warrant further research (e.g., identify suboptimal responders at Session 3, use PCMs as second-stage treatment). Utilizing the SMART methodology to develop an adaptive weight loss intervention that would outperform gold standard SBT in a randomized controlled trial is an important next step, but may require additional optimization work.Clinical Trial informationClinicalTrials.gov identifier; NCT02368002